LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

LLY

904.26

+0.95%↑

UNH

562.18

-0.6%↓

NVO

112.01

-0.39%↓

JNJ

160.15

-0.86%↓

ABBV

189.51

-0.07%↓

Accueil・Liste d'Actions・Bio-Rad Laboratories Inc

Bio-Rad Laboratories Inc

Ouvert

Secteur Soins de santé

331.59 1.25

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

322.75

Max

332.44

Chiffres clés
By Trading Economics
Revenu	-2.5B -2.2B
Ventes	28M 639M
BPA	3.11
Marge bénéficiaire	-339.153
Employés	8,030
EBITDA	-3.3B -2.7B

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+19.24 upside

Dividendes
By Dow Jones
Prochains Résultats	30 oct. 2024

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-225M 9.5B
Ouverture précédente	330.34
Clôture précédente	331.59

Sentiment de l'Actualité

By Acuity

50%

181 / 389 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

319.57 / 341.06 Support & Résistance

Bio-Rad Laboratories Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

29 oct. 2024, 23:33 UTC

Actions en Tendance

Stocks to Watch: Alphabet, Advanced Micro Devices, O-I Glass, NerdWallet

29 oct. 2024, 20:46 UTC

Actualités

Résultats

Mondelez Posts Higher Revenue, Lower Profit in 3Q

29 oct. 2024, 23:52 UTC

Résultats

Table: Samsung SDS 3Q Consolidated Net KRW185.82B Vs KRW176.57B

29 oct. 2024, 23:02 UTC

Actualités

Résultats

Google's Cloud Business Powers Accelerating Revenue Growth -- 3rd Update

29 oct. 2024, 22:58 UTC

Résultats

Tsingtao Brewery: Sluggish Domestic Beer Consumption, Higher Administrative Expenses Weighed on Results >0168.HK

29 oct. 2024, 22:58 UTC

Résultats

Tsingtao Brewery 3Q Rev CNY8.89B, Down 5.28% >0168.HK

29 oct. 2024, 22:57 UTC

Résultats

Tsingtao Brewery 3Q Net CNY1.35B , Down 9.03% >0168.HK

29 oct. 2024, 22:54 UTC

Résultats

Huaneng Power International: Lower Electricity Tariff From Domestic Operations Weighed on Revenue >0902.HK

29 oct. 2024, 22:54 UTC

Résultats

Huaneng Power International 9-Mos Rev CNY184.40B Vs. CNY191.32B >0902.HK

29 oct. 2024, 22:54 UTC

Résultats

Huaneng Power International 9-Mos Net CNY10.41B Vs. Net CNY12.56B >0902.HK

29 oct. 2024, 22:43 UTC

Résultats

Correction to Google Earnings Story -- WSJ

29 oct. 2024, 21:51 UTC

Actualités

Woolworths Cuts Expectations for 1H Australian Food Earnings

29 oct. 2024, 21:45 UTC

Résultats

Chipotle Faces Investors for First Time Since CEO's Departure -- Barrons.com

29 oct. 2024, 21:35 UTC

Market Talk

Canada Tories Grill Macklem Over Tax-Policy Ramifications -- Market Talk

29 oct. 2024, 21:32 UTC

Résultats

AMD Delivers Mixed Q3 Results, Light Guidance; Stock Sinks -- IBD

29 oct. 2024, 21:26 UTC

Actualités

Résultats

Starbucks Tells Workers to Return to the Office or Risk Getting Fired -- 2nd Update

29 oct. 2024, 21:20 UTC

Résultats

Chipotle's Sales Fell Short. Why Investors Aren't Panicking. -- Barrons.com

29 oct. 2024, 21:19 UTC

Résultats

AMD Gets an AI Boost, But Outlook Disappoints Investors -- WSJ

29 oct. 2024, 21:14 UTC

Actualités

GDP Grew in the Third Quarter, Possibly by a Lot. The Fed Will Cut Rates Anyway. -- Barrons.com

29 oct. 2024, 21:05 UTC

Market Talk

Immigration Changes Imply Lower Canada Growth, Macklem Says -- Market Talk

29 oct. 2024, 21:05 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

29 oct. 2024, 21:00 UTC

Résultats

Google's Cloud Business Powers Accelerating Revenue Growth -- 2nd Update

29 oct. 2024, 20:56 UTC

Résultats

Google Earnings Beat. Search Advertising, Cloud Growth Top Wall Street Expectations. -- IBD

29 oct. 2024, 20:54 UTC

Résultats

Caterpillar Investors Want to See Earnings Growth. They Might Not Get It. -- Barrons.com

29 oct. 2024, 20:53 UTC

Market Talk

BOC's Macklem Says Officials to Discover Where Neutral Rate Sits -- Market Talk

29 oct. 2024, 20:52 UTC

Actualités

Résultats

Google's Cloud Business Powers Accelerating Revenue Growth -- Update

29 oct. 2024, 20:51 UTC

Market Talk

Résultats

Pork Producer Profits Improve From Cheap Feed -- Market Talk

29 oct. 2024, 20:50 UTC

Résultats

AMD Gets an AI Boost, But Outlook Disappoints Investors -- WSJ

29 oct. 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

29 oct. 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

Comparaison

Variation de prix

Bio-Rad Laboratories Inc prévision

Objectif de Prix

By TipRanks

19.24% hausse

Prévisions sur 12 Mois

Moyen 381.83 USD 19.24%

Haut 446 USD

Bas 315 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

6 ratings

Achat

Maintien

Vente

Basé sur 6 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

319.57 / 341.06Support & Résistance

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Bullish events outweigh bearish events.

Sentiment

By Acuity

181 / 389Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.